Decreased serum level of sphingosine‐1‐phosphate: a novel predictor of clinical severity in COVID‐19
Open Access
- 9 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 13 (1), e13424
- https://doi.org/10.15252/emmm.202013424
Abstract
The severity of coronavirus disease 2019 (COVID‐19) is a crucial problem in patient treatment and outcome. The aim of this study is to evaluate circulating level of sphingosine‐1‐phosphate (S1P) along with severity markers, in COVID‐19 patients. One hundred‐eleven COVID‐19 patients, and forty‐seven healthy subject were included. The severity of COVID‐19 was found significantly associated to anemia, lymphocytopenia, and significant increase of neutrophil‐to‐lymphocyte ratio, ferritin, fibrinogen, aminotransferases, lactate dehydrogenase (LDH), C‐reactive protein (CRP), and D‐dimer. Serum S1P level was inversely associated with COVID‐19 severity, being significantly correlated with CRP, LDH, ferritin, and D‐dimer. The decrease in S1P was strongly associated with the number of erythrocytes, the major source of plasma S1P, and both apolipoprotein M and albumin, the major transporters of blood S1P. Not last, S1P was found to be a relevant predictor of admission to an intensive care unit, and patient’s outcome. Circulating S1P emerged as negative biomarker of severity/mortality of COVID‐19 patients. Restoring abnormal S1P levels to a normal range, may have the potential to be a therapeutic target in patients with COVID‐19.Keywords
Funding Information
- Ministero della Salute (RC2020‐400)
This publication has 40 references indexed in Scilit:
- Corticosteroids Inhibit Sphingosine 1-Phosphate–Induced Interleukin-6 Secretion from Human Airway Smooth Muscle via Mitogen-Activated Protein Kinase Phosphatase 1–Mediated Repression of Mitogen and Stress-Activated Protein Kinase 1American Journal of Respiratory Cell and Molecular Biology, 2014
- Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic networkThe FASEB Journal, 2012
- Fingolimod for Multiple SclerosisThe New England Journal of Medicine, 2012
- Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cellsMolecular and Cellular Biochemistry, 2011
- Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virusProceedings of the National Academy of Sciences of the United States of America, 2011
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences of the United States of America, 2011
- Infection and inflammation decrease apolipoprotein M expressionAtherosclerosis, 2008
- Vascular Endothelium As a Contributor of Plasma Sphingosine 1-PhosphateCirculation Research, 2008
- Erythrocytes store and release sphingosine 1‐phosphate in bloodThe FASEB Journal, 2007
- Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteinsAtherosclerosis, 2005